About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Active, specific immunotherapy for lung cancer: hurdles and strategies using genetic modification.
| Publication Type | Review |
| Authors | Korst R, Crystal R |
| Journal | Ann Thorac Surg |
| Volume | 76 |
| Issue | 4 |
| Pagination | 1319-26 |
| Date Published | 10/01/2003 |
| ISSN | 0003-4975 |
| Keywords | Genetic Techniques, Immunotherapy, Active, Lung Neoplasms |
| Abstract | Active immunotherapy for lung cancer has been a challenge because of the poor antigenic characterization of these tumors and their ability to escape the immune response. However, knowledge of the mechanisms of anti-tumor immunity has expanded significantly over the past decade, leading to the development of more novel, specific strategies for augmenting the immune response. Genetic manipulation of tumor cells, immune cells, or both, may help overcome some of the previously encountered difficulties of immunotherapy. Laboratory and clinical investigations are currently ongoing to evaluate the feasibility and potential benefit of these novel approaches. |
| DOI | 10.1016/s0003-4975(03)00651-9 |
| PubMed ID | 14530047 |